N
NeuroPace
Developing and marketing implantable devices for the treatment of neurological disorders
About NeuroPace
NeuroPace is a medical device company that has developed a brain-responsive neuromodulation system for treating epilepsy. This system, known as the RNS System, is designed to monitor and respond to a patient's brain activity to prevent seizures. The company's primary market is individuals with refractory epilepsy, a form of the condition that does not respond to medication.
The RNS System is an implantable device that provides personalized treatment by delivering electrical stimulation to the brain when it detects abnormal activity. This approach is intended to reduce the frequency and severity of seizures, improving the quality of life for patients. The company operates on a business model that involves the sale of these devices to healthcare facilities and providing ongoing support and data analysis services.
NeuroPace is a publicly traded company, and its revenue is generated through the sale of the RNS System and related components. The company is focused on expanding the adoption of its technology and continuing to develop its platform for other neurological disorders.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2021
News
Open roles
NeuroPace in the Mountain View ecosystem
The NeuroPace office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Series B and later15 investors entered at this stage
Technology Partners
Domain Associates- MEMedventure
NEA
InterWest Partners
Johnson & Johnson- MAMedVenture Associates
Johnson & Johnson Development Corporation
OrbiMed
KCK
Armentum Partners- SCSoleus Capital
Accelmed
Revelation Partners
Midcap Financial
Source: Dealroom Talent Intelligence.
See NeuroPace on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


